# PQX-CLT-013 — Parallel PQX Trial Closure

- **Date:** 2026-03-28
- **Owner:** PQX Governance
- **Status:** CLOSED
- **Trial reference:**
  - Plan: `docs/reviews/2026-03-27-parallel-pqx-trial-plan.md`
  - Action tracker: `docs/review-actions/2026-03-27-parallel-pqx-trial-actions.md`

## Trial configuration

- **Slice A:** PQX-CLT-012A — trial-plan governance execution record update
- **Slice B:** PQX-CLT-012B — action-tracker execution/closure record update
- **Baseline commit:** `1aa1ff8991234b7320102563029ea8794c00c528`
- **Branch names:**
  - Slice A: `pqx-clt-012-slice-a-plan-governance`
  - Slice B: `pqx-clt-012-slice-b-action-tracker`
- **Merge order:** Slice A first, then Slice B

## Files touched

- **Slice A files touched:**
  - `docs/reviews/2026-03-27-parallel-pqx-trial-plan.md`
- **Slice B files touched:**
  - `docs/review-actions/2026-03-27-parallel-pqx-trial-actions.md`

## Execution summary

- **Did both slices pass independently?:** YES
- **Did cross-diff confirm isolation?:** YES
- **Did any overlap occur?:** NO

## Merge behavior

- **Did Slice B behavior change after Slice A merge?:** NO
- **Any adjustments required?:** NO

## Post-merge validation

- **promotion/certification path status:** CLEAN
- **any unexpected behavior:** NO
- **attribution clarity:** CLEAR

## Decision

- **Decision:** approved
- **Basis:** no overlap detected, no ambiguity detected, and no regression observed in post-merge validation evidence.

## Forward policy

2-slice parallel PQX is approved for non-overlapping slices under current constraints.

## Key findings

- Parallel execution remained isolated at file and semantic levels for the documented trial pair.
- Sequential merges completed without conflicts and without requiring slice adjustments.
- Post-merge certification-path checks remained deterministic and clean.
